Mylan Puts Its Troubles in the Past, at a Price of $465 Million

Mylan Puts Its Troubles in the Past, at a Price of $465 Million-Bloomberg: The worst appears to be over for Mylan NV and its EpiPen controversy. It took a $465 million settlement with the U.S. Justice Department and a grilling from Congress for its chief executive officer to get there.